Skip to main content
Premium Trial:

Request an Annual Quote

Shares in Bruker, Stratagene Bounce Back

Shares in Bruker BioSciences and Stratagene continued their bumpy ride, bouncing back this week to post gains of 8.42 percent and 6.74 percent, respectively. Both firms' stocks had led decliners in the BCW Index last week, following a week of big gains.

Molecular Devices posted the largest decline for the week — 2.96 percent — giving back its gain of 2.69 percent during last week's tracking period.

Overall, the Index closed up .13 percent for the week ended Tuesday, while the Nasdaq rose .4 percent, the Nasdaq Biotech Index dropped 1.1 percent, and the Dow Jones Industrial Average fell .7 percent.

BioCommerce Week Index of Diversified Molecular Biology Tool Companies
Company
Ticker
Current Price
(Mar. 28, 2006)
Last Price
(Mar. 21, 2006)
% change
Agilent
A
36.27
37.12
-2.29
Applied Biosystems
ABI
27.52
27.13
1.44
Beckman
BEC
54.68
53.91
1.43
Bio-Rad
BIO
58.51
57.25
2.20
Bruker
BRKR
5.02
4.63
8.42
Fisher Scientific
FSH
68.81
68.55
0.38
GE
GE
33.6
34.34
-2.15
Harvard Bio
HBIO
4.33
4.27
1.41
Invitrogen
IVGN
70.72
71.29
-0.80
Molecular Devices
MDCC
31.49
32.45
-2.96
PerkinElmer
PKI
23.15
23.06
0.39
Qiagen
QGEN
14.63
14.7
-0.48
Sigma
SIAL
64.32
64.11
0.33
Stratagene
STGN
10.29
9.64
6.74
Thermo
TMO
36.12
35.58
1.52
Waters
WAT
42.79
43.47
-1.56
BCW Index Average
36.39
36.34
0.13
The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.